Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.
ID: CHEMBL1938382
Journal: J Med Chem
Title: Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.
Authors: Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA.
Abstract: Matrix metalloproteases (MMPs) play an important role in cartilage homeostasis under both normal and inflamed disease states and, thus, have become attractive targets for the treatment of arthritic diseases. Herein, we describe the identification of a potent, selective MMP-13 inhibitor, developed using fragment-based structure-guided lead identification and optimization techniques. Virtual screening methods identified a novel, indole-based MMP-13 inhibitor that bound into the S1' pocket of the protein exhibiting a novel interaction pattern hitherto not observed in MMP-13 inhibitors. X-ray crystallographic structures were used to guide the elaboration of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over nine other MMP isoforms tested.
CiteXplore: 22017539
DOI: 10.1021/jm201129m
Patent ID: ---
Protein Target Summary
Total
19
Eukaryotes
N/A
Assay Summary
Total
39
B - Binding
A - ADME
P - Physicochemical
Bioactivity Summary
Total
108
IC50
Ratio IC50
Stability
AUC
Inhibition
CL
Cmax
Drug metabolism
F
LogP
Ratio
Solubility
T1/2
Vdss
permeability

ChEMBL is part of the ELIXIR infrastructure
ChEMBL is and Elixir Core Data Resource
Learn More